<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250825066991N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-09-23</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>"The effect of vitamin C on the treatment of torn rotator cuff injuries.</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of Ascorbic Acid (Vitamin C) on Functional Recovery and Pain relief Following Open Rotator Cuff Repair: A Randomized Clinical Tria</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-09-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>64</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/85804</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Other design features: "In the intervention group, an oral vitamin C supplement at a daily dose of 500 mg will be administered starting from the first postoperative day and continued for six weeks. The selected brand is Nature Made®. The aim of this intervention is to enhance tendon healing and reduce the risk of re-tear, based on findings from recent studies, Randomization description: Patients will be randomly assigned to either the intervention or control group using block randomization implemented through specialized software. In block randomization, a predetermined number of patients (e.g., multiples of 4 or 6) are grouped into blocks, and the allocation sequence within each block is randomly generated to ensure balanced group sizes. This method helps maintain an approximately equal number of participants in both groups throughout the study, Blinding description: To ensure a double-blind study design, the supplement and placebo were manufactured to be identical in appearance, taste, and packaging. Each product was labeled with a unique code rather than a name, and these codes were accessible only to the pharmacist or principal investigator. The codes remained concealed until the end of the study. Consequently, neither the patients nor the clinical team, evaluators, or statistical analysts were aware of the type of intervention administered.</study_design>
      <phase>3</phase>
      <hc_freetext>Rotator Cuff Tear.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Participants in the intervention group will receive an oral vitamin C supplement at a daily dose of 500 mg, starting from the first day after surgery and continuing for a duration of six weeks. The selected brand for supplementation is Nature Made®. Intervention 2: Control group: The group that receives the placebo.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Participant Data File
Informed Consent Form

When:
Access to the resources will commence at the end of the Iranian calendar year 1406, corresponding approximately to March 2028.

To whom:
for all people

Conditions:
All individuals requesting to review the rotator cuff data are granted access to the dataset. Permission is hereby granted for the performance of all statistical analyses on the data. Furthermore, individuals are permitted to utilize this data in their own studies, provided that proper citation and reference is made to the original publication.

Where to obtain:
Iran University of Medical Sciences
Research Department
Adjacent to Milad Tower, Hemmat Highway
Tehran, Iran
Postal Code: 1449614535
Tel: (+98 21) 86701
Email: info@iums.ac.ir

How to obtain:
Following correspondence with the Research Department of Iran University of Medical Sciences, access to the dataset will be granted within one business week.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Alireza Ebadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 50, 2nd Floor, Golestani Alley, Taslihat Square, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1651697111</zip>
        <telephone>+98 935 998 4298</telephone>
        <email>dr.alirezaebadi@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Alireza Ebadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 50, 2nd Floor, Golestani Alley, Taslihat Square, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1651697111</zip>
        <telephone>+98 935 998 4298</telephone>
        <email>dr.alirezaebadi@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients over the age of 18 undergoing open surgical repair for rotator cuff tears
Confirmation of full-thickness tear in one or more rotator cuff tendons based on preoperative MRI assessment and intraoperative verification.
"Provision of written informed consent to participate in the study and commitment to postoperative follow-up according to the specified schedule
Adequate general health status to undergo the standard postoperative treatment and rehabilitation process</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Shoulder Revision Surgery
"Presence of neurological or muscular disorders that may affect shoulder functional outcomes (e.g., neuromuscular diseases)
Presence of significant concomitant injuries to other shoulder structures (e.g., extensive glenoid labrum tear or advanced glenohumeral joint osteoarthritis)
"Pregnancy or the presence of uncontrolled systemic diseases such as uncontrolled diabetes mellitus or advanced renal failure</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M75.12</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Complete rotator cuff tear or rupture not specified as traumatic</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Participants in the intervention group will receive an oral vitamin C supplement at a daily dose of 500 mg, starting from the first day after surgery and continuing for a duration of six weeks. The selected brand for supplementation is Nature Made®.</i_keyword>
      <i_keyword>Control group: The group that receives the placebo</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Determination of the mean (± standard deviation) scores of upper limb function (QuickDASH) in the ascorbic acid intervention group and the control group. Timepoint: Week 12 and Week 24. Method of measurement: QuickDASH Questionnaire.</prim_outcome>
      <prim_outcome>Comparison of mean upper limb functional scores (QuickDASH) between the ascorbic acid intervention group and the control group. Timepoint: Week 12 and Week 24 after surgery. Method of measurement: QuickDASH Questionnaire.</prim_outcome>
      <prim_outcome>Etermination of the mean (± standard deviation) pain intensity scores  in the ascorbic acid intervention group and the control group. Timepoint: At weeks 2, 6, 12, and 24 following the surgery. Method of measurement: Visual Analogue Scale Questionnaire.</prim_outcome>
      <prim_outcome>Comparison of the Mean Pain Intensity Between the Ascorbic Acid Group and the Control Group. Timepoint: At weeks 2, 6, 12, and 24 following the surgery. Method of measurement: Visual Analogue Scale Questionnaire.</prim_outcome>
      <prim_outcome>Determination of the Mean (Standard Deviation) of Shoulder Joint Range of Motion (ROM) in the Ascorbic Acid Group and the Control Group. Timepoint: Weeks 12 and 24 following the surgery. Method of measurement: Using an instrument called a goniometer.</prim_outcome>
      <prim_outcome>Comparison of the Mean Shoulder Joint Range of Motion (ROM) Between the Ascorbic Acid Group and the Control Group. Timepoint: Weeks 12 and 24 following the surgery. Method of measurement: Using an instrument called a goniometer.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-08-14</approval_date>
        <contact_name>Ethics Committee of the School of Medicine, Iran University of Medical Sciences.</contact_name>
        <contact_address>Iran University of Medical Sciences Adjacent to Milad Tower, Hemmat Highway Tehran, Iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
